Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
36.62
-1.07 (-2.84%)
At close: May 30, 2025, 4:00 PM
36.75
+0.13 (0.35%)
After-hours: May 30, 2025, 5:10 PM EDT

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
May '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,1392,5781,342-
Market Cap Growth
-40.94%92.14%--
Enterprise Value
1,4691,836919-
Last Close Price
36.6445.3027.94-
PB Ratio
3.173.603.53-
P/TBV Ratio
3.183.603.53-
Debt / Equity Ratio
0.020.020.01-
Quick Ratio
15.7318.4019.3015.22
Current Ratio
15.8218.5519.3815.24
Return on Equity (ROE)
-27.85%-33.22%-32.18%-
Return on Assets (ROA)
-19.65%-23.46%-21.00%-
Return on Capital (ROIC)
-20.30%-24.41%-22.18%-
Earnings Yield
-9.60%-7.07%-6.26%-
FCF Yield
-9.03%-6.69%-5.58%-
Buyback Yield / Dilution
-57.55%-120.72%-915.57%-
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q